Directed Hypercapnia as a Strategy to Wean Extracorporeal Membrane Oxygenation in COVID-19 Pneumonia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35108503.
- Also identified by DOI 10.1016/j.athoracsur.2022.01.013 and PMC identifier 8802146.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coronavirus disease 2019 pneumonia with respiratory failure refractory to maximum medical therapy has been successfully managed with venovenous extracorporeal membrane oxygenation. This report describes a process of using directed hypercapnia in 5 patients to wean them from prolonged extracorporeal support secondary to refractory hypercarbic respiratory failure.
Medical subject headings
- Extracorporeal Membrane Oxygenation
- COVID-19
- Respiratory Insufficiency
- Pneumonia